货号:A125304
同义名:
Kusaginin; trans-Verbascoside
Echinacoside是一种天然存在的咖啡酸糖苷,具有抗凋亡、抗氧化、抗炎、神经保护、肝保护等多种生物学活性,还能抑制Wnt/β-catenin信号通路,具有显著的抗骨质疏松作用。


| 规格 | 价格 | 会员价 | 库存 | 数量 | |||
|---|---|---|---|---|---|---|---|
| {[ item.pr_size ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb_sale, 1,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]} {[ getRatePriceInt(item.pr_rmb,item.pr_rate,1) ]} {[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} |
{[ getRatePriceInt(item.pr_rmb, 1,1) ]}{[ suihuo_tips(item.pr_tag_price, item.pr_am) ]} | {[ getRatePrice(item.pr_rmb_sale, 1,1,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,item.pr_rate,item.mem_rate,item.mem_isinteger) ]} {[ getRatePrice(item.pr_rmb,1,item.mem_rate,item.mem_isinteger) ]} | 现货 | 1周 咨询 | - + |
快速发货 顺丰冷链运输,1-2 天到达
品质保证
技术支持
免费溶解

| 描述 | Echinacoside, one of the phenylethanoids isolated from the stems of Cistanche salsa, effectively inhibits Wnt/β-catenin signaling. Echinacoside can dose-dependently reduce phosho-LRP6, total LRP6, phosho-Dvl2, active β-catenin, and total β-catenin protein expression level in MDA-MB-231 and MDA-MB-468 cells[3]. Echinacoside shows both anti-apoptotic and anti-inflammatory properties, characterized by a substantial inhibition of hepatocyte apoptosis and a significant reduction in the inflammatory markers[4]. Echinacoside (30 - 270 mg/kg body weight; p.o.; daily for 12 weeks) significantly reverses the increases of body weight, serum hydroxyproline (HOP) levels, and the decreases of uterus wet weight and bone mineral density (BMD) in in ovariectomized (OVX) rats[5]. Echinacoside could increase viability of rat pheochromocytoma PC12 cells injured by Aβ (β-amyloid protein) and suppress the increase in intracellular reactive oxygen species (ROS) triggered by Aβ[6]. Moreover, transient treatment with echinacoside inhibits cytochrome c release and caspase-3 activation caused by ensuing rotenone exposure via activating Trk-extracellular signal-regulated kinase (ERK) pathway in neuronal cells[7]. |
| Concentration | Treated Time | Description | References | |
| N9 microglial cells | 5–20 μM | 24 h | To investigate the effect of Echinacoside on LPS-induced N9 microglial cell activation, results showed that Echinacoside reduced the secretion of inflammatory factors and inhibited M1 polarization. | Front Pharmacol. 2023 Jan 4;13:993483. |
| rat pituitary cells | 10^-6 M to 10^-5 M | 15 and 30 min | To evaluate if echinacoside could be an agonist of growth hormone secretagogue receptor (GHSR), it was subjected to examination of the induction of growth hormone secretion from primary rat anterior pituitary cells. The results showed that echinacoside was able to significantly stimulate the secretion of growth hormones from rat pituitary cells, and this stimulation was inhibited by a GHSR inverse agonist. | Molecules. 2019 Feb 17;24(4):720. |
| Hepatic Stellate Cells (HSC-T6) | 125, 250, 500 μg/mL | 48 h | Inhibited HSC proliferation, blocked TGF-β1/smad signaling pathway, reduced mRNA and protein expression of smad2 and smad3, and increased expression of smad7. | Molecules. 2016 Jan 18;21(1):102. |
| Human umbilical vein endothelial cells (HUVECs) | 30 µM | 24 h | Echinacoside inhibited LPS-induced pathological activation and mitochondrial pathway apoptosis of endothelial cells by activating SIRT1 and promoting its expression, inhibiting NOX4 activation, and facilitating NOX4 ubiquitination degradation. | Antioxidants (Basel). 2023 Oct 29;12(11):1925. |
| lipoxygenase isolated from rat lung cytosol fraction | 296 μM | 30 min | Ineffective against LOXs in lower concentrations, while higher concentration showed similar inhibition on 8-LOX and 12-LOX (28.7% and 27%, respectively). 15-LOX was more sensitive, and the presence of echinacoside decreased its activity to 47%. | leaves and some of its constituents. Molecules. |
| Human SW480 colorectal cancer cells | 25, 35, 45, 55, 65, 75, 85, 95 μM | 24, 48 h | Echinacoside dose-dependently inhibited the growth of SW480 cells, with IC50 values of 55.39 and 35.05 μM for 24 and 48 h, respectively. | Int J Mol Sci. 2015 Jun 29;16(7):14655-68. |
| Human SW480 colorectal cancer cells | 60, 80 μM | 10 days | Echinacoside dose-dependently inhibited the colony formation of SW480 cells. | Int J Mol Sci. 2015 Jun 29;16(7):14655-68. |
| Human SW480 colorectal cancer cells | 60, 80 μM | 24 h | Echinacoside induced G1 phase cell cycle arrest in SW480 cells and upregulated the G1/S-CDK blocker CDKN1B (p21). | Int J Mol Sci. 2015 Jun 29;16(7):14655-68. |
| Human SW480 colorectal cancer cells | 60, 80 μM | 24 h | Echinacoside induced apoptosis in SW480 cells, increasing the levels of active caspase 3 and cleaved PARP proteins. | Int J Mol Sci. 2015 Jun 29;16(7):14655-68. |
| Human SW480 colorectal cancer cells | 60, 80 μM | 24 h | Echinacoside increased the level of oxidized guanine 8-oxoG in SW480 cells, indicating induction of oxidation in the nucleotide pool and/or DNA molecules. | Int J Mol Sci. 2015 Jun 29;16(7):14655-68. |
| Human SW480 colorectal cancer cells | 60, 80 μM | 24 h | Echinacoside caused extensive DNA damage in SW480 cells, as evidenced by a significant increase in 53BP1 protein. | Int J Mol Sci. 2015 Jun 29;16(7):14655-68. |
| Administration | Dosage | Frequency | Description | References | ||
| Mice | Exercise-induced injury model | Oral gavage | 100 mg/kg | Once daily for 1 week | Echinacoside significantly reduced the infiltration rate of natural killer cells (NK cells) in peripheral blood post-exercise and decreased the expression levels of key genes (GZMB, PRF1, FASLG, and CCL4). | Front Nutr. 2022 Sep 16;9:987545 |
| C57BL/6 mice | Chronic unpredictable mild stress (CUMS) induced depression model | Gavage | 15 and 60 mg/kg | Once daily for 21 days | To investigate the effect of Echinacoside on CUMS-induced depressive-like behaviors, results showed that Echinacoside reversed CUMS-induced behavioral changes, reduced levels of inflammatory factors, and increased p-CREB/CREB ratio and BDNF levels in the hippocampus. | Front Pharmacol. 2023 Jan 4;13:993483. |
| C57BL/6 mice | Sepsis-induced acute lung injury model | Intraperitoneal injection | 1 mg/kg, 5 mg/kg, 25 mg/kg | Single injection, lasting 24 hours | Echinacoside alleviated sepsis-induced acute lung injury through the SIRT1-mediated NOX4-Nrf2 axis, inhibited oxidative stress, and preserved endothelial cell function. | Antioxidants (Basel). 2023 Oct 29;12(11):1925. |
| NCT号 | 适应症或疾病 | 临床期 | 招募状态 | 预计完成时间 | 地点 |
| NCT00065715 | Common Cold | Phase 3 | Completed | - | United States, Wisconsin ... 展开 >> University of Wisconsin-Madison Department of Family Medicine Madison, Wisconsin, United States, 53706-1490 收起 << |
| NCT03463018 | Generalized Anxiety Disorder | Phase 2 | Recruiting | May 2019 | Georgia ... 展开 >> Simon Skechinashvili University Hospital Recruiting Tbilisi, Georgia Contact: Ramiaz Shengelia, PhD MD 收起 << |
| 计算器 | ||||
| 存储液制备 | ![]() |
1mg | 5mg | 10mg |
|
1 mM 5 mM 10 mM |
1.27mL 0.25mL 0.13mL |
6.36mL 1.27mL 0.64mL |
12.71mL 2.54mL 1.27mL |
|
| CAS号 | 82854-37-3 |
| 分子式 | C35H46O20 |
| 分子量 | 786.73 |
| SMILES Code | C[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H](O)[C@H](OCCC3=CC(O)=C(O)C=C3)O[C@H](CO[C@H]4[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O4)[C@H]2OC(/C=C/C5=CC(O)=C(O)C=C5)=O)O1 |
| MDL No. | MFCD00075695 |
| 别名 | Kusaginin; trans-Verbascoside; trans-Acteoside; NSC 603831 |
| 运输 | 蓝冰 |
| InChI Key | FSBUXLDOLNLABB-ISAKITKMSA-N |
| Pubchem ID | 5281771 |
| 存储条件 |
In solvent -20°C: 3-6个月 -80°C: 12个月 Pure form Inert atmosphere, 2-8°C |
| 溶解方案 |
DMSO: 50 mg/mL(63.55 mM),配合低频超声助溶,注意:DMSO长时间开封后,会吸水并导致溶解能力下降,请避免使用长期开封的DMSO H2O: 35 mg/mL(44.49 mM),配合低频超声助溶 以下溶解方案都请先按照体外实验的方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议现用现配,当天使用; 以下溶剂前显示的百分比是指该溶剂在终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶
|
沪公网安备 31011702889066号
沪ICP备2024050318号-1